Earnings Call · Q2 FY2024·2024-08-01

Q2 24EPS +31.02%·Rev n/aQ1 24EPS +6.07%·Rev n/aQ4 23EPS +3.77%·Rev n/aQ3 23EPS +9.55%·Rev n/a⚠ consensus missing

BIOGEN INC. BIIB

Chuck Triano — Head of Investor Relations

Chris Viehbacher — Chief Executive Officer

Alisha Alaimo — President, Biogen US

Priya Singhal — Head of Development (or EVP, Head of Development)

Travis Murdoch — SVP, Immunology & Gastroenterology (or similar)

Mike McDonnell — Chief Financial Officer

−1.2%1d on move date+0.2% vs SPY3d−6.9%5d−6.3%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BIIB calls or request research access.

More BIIB calls Browse calls Request research access